Novanta Inc. (NOVT) Stock Forecast
Data as of Oct 31, 2026Technology · Current price $145.26 (-3.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 25, 2026 | Robert Mason | Robert W. Baird | $150.00 | +3.3% |
| Aug 7, 2024 | Robert Mason | Robert W. Baird | $175.00 | +20.5% |
Top Analysts Covering NOVT
NOVT vs Sector & Market
| Metric | NOVT | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.39 | 2.41 |
| Analyst Count | 1 | 14 | 19 |
| Target Upside | +33.5% | +3582.4% | +21.5% |
| P/E Ratio | 99.50 | 40.37 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $271M | $272M | $274M | 1 |
| 2027-12-31 | $1.11B | $1.11B | $1.12B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.99 | $1.00 | $1.01 | 1 |
| 2027-12-31 | $4.02 | $4.05 | $4.08 | 2 |
Frequently Asked Questions
What is the analyst consensus for NOVT?
The consensus among 1 analysts covering Novanta Inc. (NOVT) is Buy with an average price target of $194.00.
What is the highest price target for NOVT?
The highest price target for NOVT is $175.00, set by Robert Mason at Robert W. Baird on 2024-08-07.
What is the lowest price target for NOVT?
The lowest price target for NOVT is $150.00, set by Robert Mason at Robert W. Baird on 2026-02-25.
How many analysts cover NOVT?
1 analysts have issued ratings for Novanta Inc. in the past 12 months.
Is NOVT a buy or sell right now?
Based on 1 analyst ratings, NOVT has a consensus rating of Buy (2.00/5) with a +33.5% upside to the consensus target of $194.00.
What are the earnings estimates for NOVT?
Analysts estimate NOVT will report EPS of $1.00 for the period ending 2026-12-31, with revenue estimated at $272M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.